Advanced Protein and Complex Structure Determination by Cryo-EM

With atomic-level structural information, our clients can design more precise and selective molecules, optimize interactions with molecular targets, and accelerate the identification of therapeutic candidates. This approach shortens development timelines and reduces costs, increases preclinical success rates, and minimizes the risk of clinical failure—offering a more rational and efficient pathway toward novel treatments and vaccines.

The study of molecular structures through cryo-electron microscopy (cryo-EM) forms the foundation of Structure-Based Drug Design (SBDD), a powerful methodology that drives the discovery and optimization of next-generation drugs and vaccines with enhanced precision and specificity.

We provide comprehensive support across all stages of the workflow—from sample preparation and grid optimization to data acquisition, 3D reconstruction, and atomic modeling.

Through our network of collaborators and partner facilities, we tailor each project to specific needs, whether in academic research, drug discovery, vaccine development, or biotechnological innovation.

Our team also offers expert guidance in experimental design and structural interpretation, ensuring high-quality, reliable results ready for publication or industrial application.